Given that the mechanism of these agents is to interrupt EGFR signaling that leads to cell growth and resistance to apoptosis, one interpretation of the above data is that while some pediatric sarcomas express EGFR (and EGFR family member receptors), they do not exclusively rely upon them for growth and survival. This evidence concerns the gene EGFR and sarcoma.